Matrix Capital Management Company, LP
Matrix Capital Management Company, LP is a hedge fund founded in 1999 by David E. Goel and Paul J. Ferri. Headquartered in Waltham, Massachusetts, it operates as a Delaware limited partnership and serves institutional investors and high-net-worth individuals. The firm manages concentrated long/short equity portfolios and focuses on growth-oriented investments, particularly in technology and life sciences. As of 2025, it employs approximately 16 staff.
Investment Strategy
Matrix Capital Management pursues a fundamental, research-driven, long/short equity strategy, emphasizing deep dive analysis and a concentrated portfolio structure. The firm's approach favors growth sectors, especially technology and healthcare, identifying companies with significant disruptive potential. The philosophy centers on high conviction positions, rigorous due diligence, and a long-term investment horizon, while using short positions primarily for risk management rather than alpha generation.
Latest 13F Filing Activity
Matrix Capital Management Company, LP filed their most recent 13F report on Jun 30, 2025 disclosing 4 equity positions with a total 13F market value of $223M. The fund increased holdings in Maze Therapeutics Inc., Aura Biosciences Inc., Zentalis Pharmaceuticals Inc. among other positions. Matrix Capital Management Company, LP reduced exposure to Globalfoundries Inc., Zentalis Pharmaceuticals Inc., Aura Biosciences Inc. among others.
Top Holdings
Equity Positions (4)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
G GFS | GLOBALFOUNDRIES INC | 59.59% | $132.7M | 3,475,000 | $54.35 | $38.20 | -$124.3M |
A AURA | AURA BIOSCIENCES INC | 19.45% | $43.3M | 6,922,870 | $13.98 | $6.26 | +$2.8M |
M MAZE | MAZE THERAPEUTICS INC | 13.69% | $30.5M | 2,486,184 | $11.01 | $12.27 | +$3.1M |
Z ZNTL | ZENTALIS PHARMACEUTICALS INC | 7.27% | $16.2M | 13,959,973 | $34.78 | $1.16 | -$6.0M |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more